Delivery Order SPE2DB20D7059-SPE2DB25FGSZ7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,302.29 to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count unit) on August 26, 2025, with ultimate completion by August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $5,185.47 to AmerisourceBergen Drug Corp for 30 tablets of Tivicay 50 mg on July 24, 2025, with completion expected by July 25, 2025. This competitively awarded, firm fixed-price contract represents a pharmaceutical supply delivery with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran...
- The Defense Logistics Agency awarded a $5,850.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count packages) on September 10, 2025, with a completion date of September 11, 2025. This non-set-aside contract represents a routine pharmaceutical procurement to support military and federal healthcare operations. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract structure. The award, issued on June 17, 2025, carries a ceiling value of $6,361.40 and requires completion by June 18, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This is a non-set-aside award issued through open competition, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $6,928.84 to AmerisourceBergen Drug Corp for Tivicay 50 mg tablets (30-count packages) on August 27, 2025, with completion scheduled for August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a single-item pharmaceutical procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this requirement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,002.96 to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count packaging). This competitively awarded, firm fixed-price delivery order was executed on June 9, 2025, with an ultimate completion date of June 10, 2025. The contract does not include a set-aside designation. Performance will be fulfilled from AmerisourceBergen Drug Corp's Conshohocken, Pennsylvania facility, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,015.64 to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) with a firm fixed price structure. This non-competitive delivery order was executed on September 10, 2025, with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location. The...
- The Defense Logistics Agency awarded a $8,005.86 delivery order to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) on June 17, 2025, with completion scheduled for June 18, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $24,055.34 to AmerisourceBergen Drug Corp for the supply of TIVICAY 50 mg tablets (30-count packages) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $4,002.93 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tivicay 50 mg tablets (30-count packages). The contract is a firm fixed-price delivery order with a completion date of September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order represents a task order...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGSZ7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,005.92 to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including critical medications across multiple therapeutic domains. This procurement structure allows the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems to efficiently access pharmaceutical commodities through a flexible contract vehicle while supporting DLA's strategic approach to pharmaceutical supply management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 9/24/25 |